THOUSANDS of women with a common form of breast cancer may soon not need any treatment at all, scientists have suggested.

Thomas Jefferson University biostatistician Terry Hyslop designed a trial showing active monitoring to be as effective as ...

Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as ...

SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET ...

Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as 'reassuring' ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DURHAM, N.C. (WNCN) — A Duke Researcher’s ...

Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received ...

Leesburg, VA, February 8, 2023—According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), ultrafast (UF) MRI provides beneficial information that can be used in ...

Women with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring showed similar quality of life (QOL), anxiety levels, and symptom trajectories compared with those receiving surgery ...

NB: This will be the subject of an embargoed virtual news briefing Dr Antonio Esgueva at 14.00 hrs CET on Tuesday 15 November. Barcelona, Spain: Using ultrasound to guide surgery for patients with ...

The 43-year-old stressed that her cancer was caught “very, very, very early,” adding that she’s going to be okay. Danielle also credited getting a yearly mammogram with helping her cancer to be ...